Literature DB >> 10654666

Heterogeneity of the mesotelencephalic dopamine fibers: physiology and pharmacology.

E L Gardner1, C R Ashby.   

Abstract

The mesotelencephalic dopamine (DA) system is heterogeneous with respect to nuclei, terminal loci, DA receptor subtypes, electrophysiological characteristics and response patterns, and neuropharmacological response to a range of agents. The majority of mesocortical and mesolimbic DA neurons originate in the ventral tegmental area. Mesostriatal DA neurons originate in substantia nigra pars compacta. DA neurons originating from the retrorubal field primarily innervate subcortical limbic and neostriatal loci. Mesostriatal terminal loci have relatively low densities of D3 and D4 receptors, compared to mesolimbic and mesocortical loci. The D1 and D2 receptors appear more homogeneously distributed. Electrophysiologically, mesostriatal DA neurons show more regularity in firing pattern (fewer bursting events), and a lower basal firing rate than mesolimbic or mesocortical neurons. Neuropharmacologically, mesocortical DA neurons are less responsive to intravenous d-amphetamine, (+)apomorphine, and chronic antipsychotic drug treatment. Mesocortical DA neurons are also relatively insensitive to iontophoretically applied DA, a finding congruent with their reported relative lack of somatodendritic autoreceptors. Neurochemically, mesoaccumbens DA neurons are more sensitive to systemic administration of drugs with addictive liability.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10654666     DOI: 10.1016/s0149-7634(99)00048-2

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  13 in total

Review 1.  Neurobiologic processes in drug reward and addiction.

Authors:  Bryon Adinoff
Journal:  Harv Rev Psychiatry       Date:  2004 Nov-Dec       Impact factor: 3.732

2.  Linguistic correlates of asymmetric motor symptom severity in Parkinson's Disease.

Authors:  Thomas Holtgraves; Patrick McNamara; Kevin Cappaert; Raymond Durso
Journal:  Brain Cogn       Date:  2009-09-13       Impact factor: 2.310

3.  mRNA expression of dopamine receptors in peripheral blood lymphocytes of computer game addicts.

Authors:  Nasim Vousooghi; Seyed Zeinolabedin Zarei; Mitra-Sadat Sadat-Shirazi; Fatemeh Eghbali; Mohammad Reza Zarrindast
Journal:  J Neural Transm (Vienna)       Date:  2015-05-14       Impact factor: 3.575

4.  Sex Differences in Midbrain Dopamine D2-Type Receptor Availability and Association with Nicotine Dependence.

Authors:  Kyoji Okita; Nicole Petersen; Chelsea L Robertson; Andy C Dean; Mark A Mandelkern; Edythe D London
Journal:  Neuropsychopharmacology       Date:  2016-06-22       Impact factor: 7.853

5.  Mesocorticolimbic Pathways Encode Cue-Based Expectancy Effects on Pain.

Authors:  Yiheng Tu; Yanzhi Bi; Libo Zhang; Hua Wei; Li Hu
Journal:  J Neurosci       Date:  2019-11-06       Impact factor: 6.167

6.  Differential desensitization and distribution of nicotinic acetylcholine receptor subtypes in midbrain dopamine areas.

Authors:  Julian R A Wooltorton; Volodymyr I Pidoplichko; Ron S Broide; John A Dani
Journal:  J Neurosci       Date:  2003-04-15       Impact factor: 6.167

7.  Cebranopadol Blocks the Escalation of Cocaine Intake and Conditioned Reinstatement of Cocaine Seeking in Rats.

Authors:  Giordano de Guglielmo; Alessandra Matzeu; Jenni Kononoff; Julia Mattioni; Rémi Martin-Fardon; Olivier George
Journal:  J Pharmacol Exp Ther       Date:  2017-06-23       Impact factor: 4.030

8.  From metabolic connectivity to molecular connectivity: application to dopaminergic pathways.

Authors:  Antoine Verger; Tatiana Horowitz; Mohammad B Chawki; Alexandre Eusebio; Manon Bordonne; Jean-Philippe Azulay; Nadine Girard; Eric Guedj
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-11-18       Impact factor: 9.236

Review 9.  Agents in development for the management of cocaine abuse.

Authors:  David A Gorelick; Eliot L Gardner; Zheng-Xiong Xi
Journal:  Drugs       Date:  2004       Impact factor: 9.546

10.  On the origin of cortical dopamine: is it a co-transmitter in noradrenergic neurons?

Authors:  Paola Devoto; Giovanna Flore
Journal:  Curr Neuropharmacol       Date:  2006-04       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.